Bifunctional Therapy by Zinc‐Cobalt Bimetal‐Organic Framework with Encapsulated Doxorubicin to Overcome Drug‐Resistance

Licheng Wang,Hanyi Hou,Xinqi Jiao,Tianyin Shen,Yingying Liu,Yida Qiao,Yu Liu,Yuan Lu,Jun Ge
DOI: https://doi.org/10.1002/cnma.201900440
IF: 3.82
2019-01-01
ChemNanoMat
Abstract:Drug resistance is a major challenge in antineoplastic chemotherapy, which could be possibly solved through multifunctional anti-cancer therapy. This study constructs a drug delivery system with Zn(II)-Co(II) bimetal-organic framework nanoparticles with encapsulated doxorubicin (DOX), a model chemotherapeutic molecule. Beyond conventional therapeutic mechanisms powered by DOX, the newly applied Co(II) to the drug delivery system catalyzes the generation of reactive oxygen species (ROS) through a Fenton-like process, leading to necrosis due to oxidative stress beyond threshold. The system displayed DOX-based and Co(II)-based dual mechanism anti-cancer therapy to overcome DOX-resistance while demonstrating significant cytotoxicity promotion in non-resistant cell lines, as effects of ROS were further acknowledged by following cell characteristic examinations. This bifunctional DOX-encapsulated bimetal-organic framework nanoparticle opens a new strategy to construct multiple anti-cancer mechanism drug delivery systems with great simplicity.
What problem does this paper attempt to address?